+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Dysmenorrhea Treatment Market by Type, Treatment, Distribution Channel, End-Users - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5896360
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Dysmenorrhea Treatment Market grew from USD 7.16 billion in 2023 to USD 7.80 billion in 2024. It is expected to continue growing at a CAGR of 8.98%, reaching USD 13.09 billion by 2030.

Dysmenorrhea, commonly known as painful menstruation, represents a significant market within women’s health, driven by the increasing prevalence of menstrual disorders. The scope of this market encompasses pharmaceutical treatments, over-the-counter pain relief products, thermal treatments, lifestyle modifications, and medical devices. The necessity for effective dysmenorrhea treatments is underscored by the impact of the condition on women's quality of life and productivity. Its application spans various demographics, from adolescent girls to menopausal women, while end-users include individual consumers, healthcare providers, and clinics. Market growth is fueled by heightened awareness of women's health issues, advancements in treatment options, and the development of personalized medicine. The rising acceptance of non-steroidal anti-inflammatory drugs (NSAIDs), hormonal therapies, and novel treatment solutions such as cannabis-derived products, are pivotal growth factors. Emerging opportunities within the market are found in developing non-invasive treatments and expanding telemedicine services to increase accessibility, particularly in underserved areas. However, market growth is challenged by the side effects associated with conventional treatments, lack of awareness in developing regions, and stigmas surrounding menstrual health. Regulatory hurdles and the high cost of novel therapies also pose limitations. To foster innovation, investment in research exploring the genetic and environmental factors influencing dysmenorrhea can lead to more targeted therapies. The market is characterized by high competition, with numerous players focusing on product diversification and geographic expansion. Businesses can capitalize on growing consumer preference for natural and herbal remedies, as well as leveraging digital platforms for education and distribution. Overall, developments in functional pain relief options, improved understanding of the pathophysiology of dysmenorrhea, and innovative service delivery models are pivotal for sustaining market growth and addressing unmet needs.

Understanding Market Dynamics in the Dysmenorrhea Treatment Market

The Dysmenorrhea Treatment Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Prevalence of dysmenorrhea and the need for effective treatment options
    • Growing awareness about women’s reproductive health and government initiatives to expand healthcare for women
  • Market Restraints
    • Issues associated with product recalls for dysmenorrhea drugs and devices
  • Market Opportunities
    • Advancements in therapy for dysmenorrhea and the emergence of novel drugs
    • Adoption of wearable technology and the proliferation of digital health
  • Market Challenges
    • Societal barriers and stigmatization regarding dysmenorrhea management

Exploring Porter’s Five Forces for the Dysmenorrhea Treatment Market

Porter’s Five Forces framework further strengthens the insights of the Dysmenorrhea Treatment Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Dysmenorrhea Treatment Market

External macro-environmental factors deeply influence the performance of the Dysmenorrhea Treatment Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Dysmenorrhea Treatment Market

The Dysmenorrhea Treatment Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Dysmenorrhea Treatment Market

The Dysmenorrhea Treatment Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Key Company Profiles

The report delves into recent significant developments in the Dysmenorrhea Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AA Pharma Inc., Cora Life by LYV Life, Inc., Pfizer Inc., Takeda Pharmaceutical Company Limited., Merck & Co., Inc., AbbVie Inc., Alfa Pharma GmbH, ASKA Pharmaceutical Co., Ltd., Bayer AG, Lupin Pharmaceuticals, Inc., Myoovi, Viatris Inc., Myovant Sciences by Sumitovant Biopharma, Inc., Sanofi S.A., Cumberland Pharmaceuticals Inc., GlaxoSmithKline PLC, Comforté Cream by PMS4PMS, LLC, Micro Labs Limited, LGM Pharma, Dr. Reddy's Laboratories Ltd., Gedeon Richter Plc., Alvogen, Inc., Endo Pharmaceuticals Inc., Perrigo Company PLC, Teva Pharmaceutical Industries Ltd., Ovira, Ferring B.V., F. Hoffmann-La Roche AG, Rael, Inc., Novartis AG, Haleon PLC, Johnson & Johnson Services, Inc., Hikma Pharmaceuticals PLC, Livia by iPulse Medical Ltd., and Sun Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Dysmenorrhea Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Primary Dysmenorrhea
    • Secondary Dysmenorrhea
  • Treatment
    • Medication
      • Combined Oral Contraceptive Pills
      • Cox-2 Inhibitors
      • Non-Steroidal Anti-Inflammatory Drugs
      • Over-The-Counter Medications
      • Transdermal Glyceryl Trinitrate
    • Surgery
      • Hysterectomy
      • Intrauterine Device
      • Laparoscopic Uterosacral Nerve Ablation
      • Levonorgestrel Intrauterine System (LN-IUS)
      • Presacral Neurectomy
    • Therapeutics
      • Alternative Therapies
      • Psychological Therapies
  • Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
  • End-Users
    • Homecare
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of dysmenorrhea and the need for effective treatment options
5.1.1.2. Growing awareness about women’s reproductive health and government initiatives to expand healthcare for women
5.1.2. Restraints
5.1.2.1. Issues associated with product recalls for dysmenorrhea drugs and devices
5.1.3. Opportunities
5.1.3.1. Advancements in therapy for dysmenorrhea and the emergence of novel drugs
5.1.3.2. Adoption of wearable technology and the proliferation of digital health
5.1.4. Challenges
5.1.4.1. Societal barriers and stigmatization regarding dysmenorrhea management
5.2. Market Segmentation Analysis
5.2.1. Type: Wide occurrence of primary dysmenorrhea and extensive need for pain relief management
5.2.2. Treatment: Adoption of hysterectomy treatment to provide permanent relief from dysmenorrhea
5.2.3. Distribution Channel: Growing preference for online pharmacies due to their convenience, discreteness, and competitive pricing of medications and pain relief patches
5.2.4. End-Users: Increasing adoption of dysmenorrhea treatment in the homecare segment as it is easily accessible and cost-effective
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Dysmenorrhea Treatment Market, by Type
6.1. Introduction
6.2. Primary Dysmenorrhea
6.3. Secondary Dysmenorrhea
7. Dysmenorrhea Treatment Market, by Treatment
7.1. Introduction
7.2. Medication
7.2.1. Combined Oral Contraceptive Pills
7.2.2. Cox-2 Inhibitors
7.2.3. Non-Steroidal Anti-Inflammatory Drugs
7.2.4. Over-The-Counter Medications
7.2.5. Transdermal Glyceryl Trinitrate
7.3. Surgery
7.3.1. Hysterectomy
7.3.2. Intrauterine Device
7.3.3. Laparoscopic Uterosacral Nerve Ablation
7.3.4. Levonorgestrel Intrauterine System (LN-IUS)
7.3.5. Presacral Neurectomy
7.4. Therapeutics
7.4.1. Alternative Therapies
7.4.2. Psychological Therapies
8. Dysmenorrhea Treatment Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacy
8.3. Online Pharmacy
8.4. Retail Pharmacy
9. Dysmenorrhea Treatment Market, by End-Users
9.1. Introduction
9.2. Homecare
9.3. Hospitals
9.4. Specialty Clinics
10. Americas Dysmenorrhea Treatment Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Dysmenorrhea Treatment Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Dysmenorrhea Treatment Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Mithra Submits Marketing Approval Application in Japan to Combat Dysmenorrhea
13.3.2. Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia
13.3.3. Mithra to Receive EUR 2.5 Million from Fuji Pharma for Dysmenorrhea Treatment in Japan
13.3.4. Sumitomo Pharma and Pfizer in Canada Receive Health Canada Approval for MYFEMBREE
13.3.5. Gedeon Richter and Sumitomo Pharma Receive Positive CHMP Opinion for RYEQO for Treatment of Endometriosis
13.3.6. How New Tech from Montreal Could Help the Fight Against Period Cramps
13.3.7. Chugai and Biofourmis Enter into New Partnership Focused on Data-Driven Virtual Care for Endometriosis-Related Pain
13.3.8. Daré Bioscience Begins Phase I Trial of Primary Dysmenorrhea Therapy
13.3.9. Healthtech Startup Ovira is Helping Women Tackle a Key Problem - Drug-Free Period Pain Relief
13.3.10. Cora Reimagines Period Care with a New Beauty-Inspired Look and Expanded Wellness Portfolio to Make Comfort Accessible for Everyone
List of Figures
FIGURE 1. DYSMENORRHEA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. DYSMENORRHEA TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 9. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 11. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 13. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. DYSMENORRHEA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. DYSMENORRHEA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. DYSMENORRHEA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. DYSMENORRHEA TREATMENT MARKET DYNAMICS
TABLE 7. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PRIMARY DYSMENORRHEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SECONDARY DYSMENORRHEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY COMBINED ORAL CONTRACEPTIVE PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY COX-2 INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY OVER-THE-COUNTER MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY TRANSDERMAL GLYCERYL TRINITRATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HYSTERECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY INTRAUTERINE DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY LAPAROSCOPIC UTEROSACRAL NERVE ABLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY LEVONORGESTREL INTRAUTERINE SYSTEM (LN-IUS), BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PRESACRAL NEURECTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ALTERNATIVE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY PSYCHOLOGICAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL DYSMENORRHEA TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 50. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 59. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 62. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 63. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 64. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. CANADA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 66. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 68. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 69. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 70. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 71. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. MEXICO DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES DYSMENORRHEA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 86. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 88. ASIA-PACIFIC DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 92. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 93. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 94. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 95. AUSTRALIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 96. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 98. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 99. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 100. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 101. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. CHINA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 103. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 105. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 106. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 107. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 108. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. INDIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 113. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 114. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 115. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 116. INDONESIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 117. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 119. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 120. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 121. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 122. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. JAPAN DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 127. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 128. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 129. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. MALAYSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 134. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 135. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 136. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. PHILIPPINES DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 141. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 142. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 143. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. SINGAPORE DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 148. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 149. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 150. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 155. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 156. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 157. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 158. TAIWAN DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 159. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 161. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 162. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 163. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 164. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. THAILAND DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 169. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 170. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 171. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. VIETNAM DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 181. DENMARK DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 182. DENMARK DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 183. DENMARK DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 184. DENMARK DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 185. DENMARK DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 186. DENMARK DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 187. DENMARK DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 188. EGYPT DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 189. EGYPT DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 190. EGYPT DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 191. EGYPT DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 192. EGYPT DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 193. EGYPT DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. EGYPT DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 195. FINLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 196. FINLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 197. FINLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 198. FINLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 199. FINLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 200. FINLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. FINLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 202. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 204. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 205. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 206. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 207. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. FRANCE DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 209. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 210. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 211. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 212. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 213. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 214. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. GERMANY DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 219. ISRAEL DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 220. ISRAEL DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 221. ISRAEL DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 222. ISRAEL DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 223. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 224. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 225. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 226. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 227. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 228. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 229. ITALY DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 233. NETHERLANDS DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 234. NETHERLANDS DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 235. NETHERLANDS DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. NETHERLANDS DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 244. NORWAY DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 245. NORWAY DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 246. NORWAY DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 247. NORWAY DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 248. NORWAY DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 249. NORWAY DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. NORWAY DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 251. POLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 252. POLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 253. POLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 254. POLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 255. POLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 256. POLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 257. POLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 258. QATAR DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 259. QATAR DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 260. QATAR DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 261. QATAR DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 262. QATAR DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 263. QATAR DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. QATAR DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 276. SAUDI ARABIA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 278. SAUDI ARABIA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 286. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 287. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 288. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 289. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 290. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 291. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. SPAIN DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 296. SWEDEN DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 297. SWEDEN DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 298. SWEDEN DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 299. SWEDEN DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 305. SWITZERLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 306. SWITZERLAND DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 307. TURKEY DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 308. TURKEY DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 309. TURKEY DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 310. TURKEY DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 311. TURKEY DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 312. TURKEY DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 313. TURKEY DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 322. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY MEDICATION, 2018-2030 (USD MILLION)
TABLE 324. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 325. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 326. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 327. UNITED KINGDOM DYSMENORRHEA TREATMENT MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 328. DYSMENORRHEA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 329. DYSMENORRHEA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Dysmenorrhea Treatment market, which are profiled in this report, include:
  • Abbott Laboratories
  • AA Pharma Inc.
  • Cora Life by LYV Life, Inc.
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited.
  • Merck & Co., Inc.
  • AbbVie Inc.
  • Alfa Pharma GmbH
  • ASKA Pharmaceutical Co., Ltd.
  • Bayer AG
  • Lupin Pharmaceuticals, Inc.
  • Myoovi
  • Viatris Inc.
  • Myovant Sciences by Sumitovant Biopharma, Inc.
  • Sanofi S.A.
  • Cumberland Pharmaceuticals Inc.
  • GlaxoSmithKline PLC
  • Comforté Cream by PMS4PMS, LLC
  • Micro Labs Limited
  • LGM Pharma
  • Dr. Reddy's Laboratories Ltd.
  • Gedeon Richter Plc.
  • Alvogen, Inc.
  • Endo Pharmaceuticals Inc.
  • Perrigo Company PLC
  • Teva Pharmaceutical Industries Ltd.
  • Ovira
  • Ferring B.V.
  • F. Hoffmann-La Roche AG
  • Rael, Inc.
  • Novartis AG
  • Haleon PLC
  • Johnson & Johnson Services, Inc.
  • Hikma Pharmaceuticals PLC
  • Livia by iPulse Medical Ltd.
  • Sun Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information